ALC
IDXX icon

Alexander Labrunerie & Co’s Idexx Laboratories IDXX Stock Holding History

Alexander Labrunerie & Co’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-358
Closed -$201K – 128
2026
Q1 		$201K Hold
358
– – 0.08% 121
2025
Q4 		$242K Hold
358
– – 0.09% 98
2025
Q3 		$229K Buy
+358
New +$217K 0.08% 103

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Alexander Labrunerie & Co's IDXX Position: Q2 2026 in Review

Alexander Labrunerie & Co sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 358 shares — an estimated $201K sold.

Alexander Labrunerie & Co first reported a position in IDXX in Q3 2025 and held it in 3 quarters. The position peaked at $242K in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Alexander Labrunerie & Co reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • Alexander Labrunerie & Co sold 358 Idexx Laboratories shares in Q2 2026, an estimated $201K.
  • Alexander Labrunerie & Co first reported a position in Idexx Laboratories in Q3 2025 and held it in 3 quarters.
  • Alexander Labrunerie & Co's Idexx Laboratories position peaked at $242K in Q4 2025.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Alexander Labrunerie & Co's 13F filing for Q2 2026, filed 3 Aug 2026.